Guru Ownership Trend
Guru Analysis for Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (ORMP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $884,078.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $85,064 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 24.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Oramed Pharmaceuticals Inc. (ORMP)
Major holders include Renaissance Technologies (RenTech) ($884,078). According to the latest reported data, 1 tracked investment managers collectively hold approximately 183,800 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $85,064, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited ORMP. The total reported sell value was $88,577.
Yes, 0 managers opened new positions in ORMP, and 1 increased their existing holdings. The total reported buy value was $173,641.